Table 2 Response to treatment: intention-to-treat analysis (n=46)

From: Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil

Complete responses

3 (7 %)

Partial responses

16 (35%)

Stable disease

14 (30%)

Failures

13 (28%)

Response rate (95% CL)

42% (28–55)

Back to article page